• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用商业软件提取的治疗前和近距离放疗前MRI一阶影像组学特征作为宫颈癌放疗生存预测指标 目的。

Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives.

作者信息

Sittiwong Wiwatchai, Dankulchai Pittaya, Wongsuwan Pitchayut, Prasartseree Tissana, Thaweerat Wajana, Thornsri Nerisa, Tuntapakul Pongpop

机构信息

Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Research Unit, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand.

出版信息

Clin Transl Radiat Oncol. 2025 Apr 19;53:100965. doi: 10.1016/j.ctro.2025.100965. eCollection 2025 Jul.

DOI:10.1016/j.ctro.2025.100965
PMID:40331124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12051114/
Abstract

MATERIALS AND METHODS

The study included 100 patients with LACC who underwent definitive CCRT with IMRT/VMAT technique followed by 3D-IGABT. MRI-based contouring included T2WI and DWI images for primary tumor (GTVp) and lymph nodes (GTVn). The contours were imported to MIM software to extract first-order radiomic features. Radiomic values from pre-treatment (PreRx), pre-brachytherapy (PreBT), differences between PreRx and PreBT (Diff) radiomic and clinical factors were analyzed using univariate and multivariate Cox regression analysis. Predictive models of PFS, LRFS, DMFS, and OS were created along with the optimism index and calibration plot.

RESULTS

The median follow-up time was 24.5 months. The 2-year of PFS, LRFS, DMFS, and OS rates were 71, 88.6, 83.1, and 83.5 %, respectively. For all clinical outcomes, CF + RF combined from PreRx and PreBT resulted in the highest Harrell's C-index compared with the CF or RF alone. Compare with Diff models, models from PreRx and PreBT resulted in higher Harrell's C-index. The C-indexes from the CF + RF model from PreRx and PreBT for PFS, LRFS, DMFS, and OS were 0.739, 0.873, 0.830 and 0.967 with the optimism indexes of 0.312, 0.381, 0.316, and 0.242, respectively.

CONCLUSION

Radiomic features from the first-order statistics added values to clinical factors to predict the outcomes after CCRT. The highest prediction model performance was for the combined clinical and radiomics from PreRx and PreBT.

摘要

材料与方法

本研究纳入了100例接受调强放射治疗(IMRT)/容积调强弧形放疗(VMAT)技术的根治性同步放化疗后行三维图像引导下近距离放疗(3D-IGABT)的局部晚期宫颈癌(LACC)患者。基于磁共振成像(MRI)的轮廓勾画包括用于勾画原发肿瘤(GTVp)和淋巴结(GTVn)的T2加权成像(T2WI)和扩散加权成像(DWI)图像。将轮廓导入MIM软件以提取一阶放射组学特征。使用单因素和多因素Cox回归分析对治疗前(PreRx)、近距离放疗前(PreBT)、PreRx与PreBT之间的差异(Diff)的放射组学和临床因素的放射组学值进行分析。创建了无进展生存期(PFS)、局部区域复发无进展生存期(LRFS)、远处转移无进展生存期(DMFS)和总生存期(OS)的预测模型以及乐观指数和校准图。

结果

中位随访时间为24.5个月。2年PFS、LRFS、DMFS和OS率分别为71%、88.6%、83.1%和83.5%。对于所有临床结局,与单独的临床因素(CF)或放射组学因素(RF)相比,PreRx和PreBT联合的CF + RF产生了最高的Harrell C指数。与Diff模型相比,PreRx和PreBT的模型产生了更高的Harrell C指数。PreRx和PreBT的CF + RF模型对于PFS、LRFS、DMFS和OS的C指数分别为0.739、0.873、0.830和0.967,乐观指数分别为0.312、0.381、0.316和0.242。

结论

一阶统计量的放射组学特征为临床因素增加了价值,以预测同步放化疗后的结局。最高的预测模型性能是PreRx和PreBT联合的临床和放射组学模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/5225261a7f87/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/b2da3e9ad844/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/d77930883f82/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/6b52466d71d9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/5225261a7f87/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/b2da3e9ad844/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/d77930883f82/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/6b52466d71d9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/694b/12051114/5225261a7f87/gr4.jpg

相似文献

1
Pre-Treatment and Pre-Brachytherapy MRI first-order Radiomic Features by a Commercial software as survival predictors in radiotherapy for cervical cancer Objectives.使用商业软件提取的治疗前和近距离放疗前MRI一阶影像组学特征作为宫颈癌放疗生存预测指标 目的。
Clin Transl Radiat Oncol. 2025 Apr 19;53:100965. doi: 10.1016/j.ctro.2025.100965. eCollection 2025 Jul.
2
Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute Experience.CT 引导与全 MRI 引导宫颈癌近距离放疗临床结局比较:单中心经验。
Clin Oncol (R Coll Radiol). 2024 Nov;36(11):e456-e467. doi: 10.1016/j.clon.2024.08.003. Epub 2024 Aug 10.
3
MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer.局部晚期宫颈癌放化疗期间用于预后评估的MRI影像组学变化分析
BMC Cancer. 2025 Jan 22;25(1):122. doi: 10.1186/s12885-025-13509-1.
4
Tumor Prognostic Prediction of Nasopharyngeal Carcinoma Using CT-Based Radiomics in Non-Chinese Patients.基于CT的放射组学对非中国患者鼻咽癌的肿瘤预后预测
Front Oncol. 2022 Jan 28;12:775248. doi: 10.3389/fonc.2022.775248. eCollection 2022.
5
Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer.治疗前T2加权磁共振影像组学用于预测局部晚期宫颈癌图像引导自适应近距离放疗后的局部区域复发
J Contemp Brachytherapy. 2024 Jun;16(3):193-201. doi: 10.5114/jcb.2024.141458. Epub 2024 Jun 28.
6
MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach.基于 MRI 的放射组学:在采用个体化综合治疗方法治疗局部晚期宫颈癌方面的应用前景。
Tumori. 2022 Aug;108(4):376-385. doi: 10.1177/03008916211014274. Epub 2021 Jul 8.
7
Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.从扩散加权磁共振成像中提取的影像组学特征可预测骨肉瘤的预后。
J Bone Oncol. 2019 Oct 4;19:100263. doi: 10.1016/j.jbo.2019.100263. eCollection 2019 Dec.
8
MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.基于 MRI 的放射组学预测同步放化疗治疗局部晚期宫颈鳞癌患者生存价值
Cancer Imaging. 2022 Jul 16;22(1):35. doi: 10.1186/s40644-022-00474-2.
9
Utility of CT Radiomics and Delta Radiomics for Survival Evaluation in Locally Advanced Nasopharyngeal Carcinoma with Concurrent Chemoradiotherapy.CT影像组学和Delta影像组学在局部晚期鼻咽癌同步放化疗生存评估中的应用
Diagnostics (Basel). 2024 Apr 30;14(9):941. doi: 10.3390/diagnostics14090941.
10
Early prediction of progression-free survival of patients with locally advanced nasopharyngeal carcinoma using multi-parametric MRI radiomics.使用多参数MRI影像组学对局部晚期鼻咽癌患者无进展生存期进行早期预测
BMC Cancer. 2025 Mar 21;25(1):519. doi: 10.1186/s12885-025-13899-2.

本文引用的文献

1
Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer.治疗前T2加权磁共振影像组学用于预测局部晚期宫颈癌图像引导自适应近距离放疗后的局部区域复发
J Contemp Brachytherapy. 2024 Jun;16(3):193-201. doi: 10.5114/jcb.2024.141458. Epub 2024 Jun 28.
2
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.局部晚期宫颈癌患者采用诱导化疗联合标准放化疗与单纯标准放化疗的比较(GCIG INTERLACE):一项国际多中心随机 3 期临床试验。
Lancet. 2024 Oct 19;404(10462):1525-1535. doi: 10.1016/S0140-6736(24)01438-7. Epub 2024 Oct 14.
3
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.帕博利珠单抗或安慰剂联合放化疗,随后行帕博利珠单抗或安慰剂巩固治疗新诊断的、高危、局部晚期宫颈癌(ENGOT-cx11/GOG-3047/KEYNOTE-A18):一项随机、双盲、III 期临床研究。
Lancet. 2024 Apr 6;403(10434):1341-1350. doi: 10.1016/S0140-6736(24)00317-9. Epub 2024 Mar 20.
4
A general framework to develop a radiomic fingerprint for progression-free survival in cervical cancer.用于开发宫颈癌无进展生存期放射组学特征的一般框架。
Brachytherapy. 2023 Nov-Dec;22(6):728-735. doi: 10.1016/j.brachy.2023.06.004. Epub 2023 Aug 12.
5
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.辅助化疗联合放化疗作为局部晚期宫颈癌的初始治疗与单纯放化疗比较(OUTBACK):一项国际性、开放标签、随机、3 期临床试验。
Lancet Oncol. 2023 May;24(5):468-482. doi: 10.1016/S1470-2045(23)00147-X. Epub 2023 Apr 17.
6
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.局部晚期宫颈癌放化疗联合磁共振成像引导近距离放疗后局部失败的危险因素:EMBRACE-I研究结果
J Clin Oncol. 2023 Apr 1;41(10):1933-1942. doi: 10.1200/JCO.22.01096. Epub 2023 Jan 4.
7
Nomogram models for the prognosis of cervical cancer: A SEER-based study.宫颈癌预后的列线图模型:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2022 Oct 6;12:961678. doi: 10.3389/fonc.2022.961678. eCollection 2022.
8
MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.基于 MRI 的放射组学预测同步放化疗治疗局部晚期宫颈鳞癌患者生存价值
Cancer Imaging. 2022 Jul 16;22(1):35. doi: 10.1186/s40644-022-00474-2.
9
Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.宫颈癌患者行外照射放疗和图像引导自适应近距离放疗后,阴道 11 点和容积剂量与晚期阴道并发症的关系。
Radiother Oncol. 2022 Sep;174:77-86. doi: 10.1016/j.radonc.2022.07.009. Epub 2022 Jul 15.
10
Development and validation of a prognostic prediction model including the minor lymphatic pathway for distant metastases in cervical cancer patients.开发和验证包括宫颈癌患者小淋巴通路的远处转移预后预测模型。
Sci Rep. 2022 Jun 14;12(1):9873. doi: 10.1038/s41598-022-13616-0.